300030 阳普医疗
2026/09 - 九个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.9962.368-17.732-8.386-22.224
总资产报酬率 ROA (%)1.9291.280-8.831-4.236-11.723
投入资产回报率 ROIC (%)2.3591.542-10.498-5.053-13.731

边际利润分析
销售毛利率 (%)43.59543.00641.39339.82537.202
营业利润率 (%)7.5124.288-20.114-6.331-29.945
息税前利润/营业总收入 (%)7.2775.593-19.230-4.143-27.977
净利润/营业总收入 (%)5.4713.129-20.625-9.342-27.195

收益指标分析
经营活动净收益/利润总额(%)180.140147.971-8.94871.59519.605
价值变动净收益/利润总额(%)-21.49145.39952.813-17.28524.777
营业外收支净额/利润总额(%)1.0188.2102.8405.2220.679

偿债能力分析
流动比率 (X)1.5981.3321.1501.1011.125
速动比率 (X)1.2471.0760.9500.8820.907
资产负债率 (%)28.07636.20848.24846.53947.335
带息债务/全部投入资本 (%)11.68623.09238.09035.61033.711
股东权益/带息债务 (%)725.484317.729153.313168.199179.772
股东权益/负债合计 (%)245.003166.835101.075108.960106.343
利息保障倍数 (X)-23.2966.070-13.060-1.633-12.874

营运能力分析
应收账款周转天数 (天)88.088104.512105.948114.479112.958
存货周转天数 (天)103.571119.529124.342126.112117.335